These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Macrovascular complications of metabolic syndrome: an early intervention is imperative. Tenenbaum A; Motro M; Schwammenthal E; Fisman EZ Int J Cardiol; 2004 Nov; 97(2):167-72. PubMed ID: 15458679 [TBL] [Abstract][Full Text] [Related]
25. Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol. Gómez-Marcos MA; Recio-Rodríguez JI; Rodríguez-Sánchez E; Castaño-Sánchez Y; de Cabo-Laso A; Sánchez-Salgado B; Rodríguez-Martín C; Castaño-Sánchez C; Gómez-Sánchez L; García-Ortiz L BMC Public Health; 2010 Mar; 10():143. PubMed ID: 20298558 [TBL] [Abstract][Full Text] [Related]
26. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Misra A; Khurana L Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153 [TBL] [Abstract][Full Text] [Related]
27. Influence of metabolic syndrome profile on cardiovascular risk. Mitu F; Cobzaru R; Leon MM Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):308-14. PubMed ID: 24340509 [TBL] [Abstract][Full Text] [Related]
28. Hypertriglyceridemia secondary to obesity and diabetes. Subramanian S; Chait A Biochim Biophys Acta; 2012 May; 1821(5):819-25. PubMed ID: 22005032 [TBL] [Abstract][Full Text] [Related]
29. [Metabolic syndrome: "common soil" for diabetes and atherosclerosis. Novel approaches to an integrated therapy]. Hanefeld M; Metzler W; Köhler C; Schaper F Herz; 2006 May; 31(3):246-54; quiz 255. PubMed ID: 16770562 [TBL] [Abstract][Full Text] [Related]
30. Lifestyle modification and endothelial function in obese subjects. Hamdy O Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597 [TBL] [Abstract][Full Text] [Related]
31. The metabolic vascular syndrome - guide to an individualized treatment. Hanefeld M; Pistrosch F; Bornstein SR; Birkenfeld AL Rev Endocr Metab Disord; 2016 Mar; 17(1):5-17. PubMed ID: 26956847 [TBL] [Abstract][Full Text] [Related]
32. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk. Després JP Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261 [No Abstract] [Full Text] [Related]
33. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Esser N; Paquot N; Scheen AJ Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753 [TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome in the prevention of cardiovascular diseases and diabetes--still a matter of debate? Ma X; Zhu S Eur J Clin Nutr; 2013 May; 67(5):518-21. PubMed ID: 23403882 [TBL] [Abstract][Full Text] [Related]
35. Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine. Dominiczak MH Clin Chem Lab Med; 2003 Sep; 41(9):1266-78. PubMed ID: 14598880 [TBL] [Abstract][Full Text] [Related]